Analysis of US Patent 10,966,939: Scope, Claims, and Patent Landscape
What Does US Patent 10,966,939 Cover?
US Patent 10,966,939 was granted on March 16, 2021, to cover a novel pharmaceutical compound and its therapeutic applications. The patent relates primarily to chemical entities targeting specific disease pathways, with emphasis on conditions such as cancer, autoimmune diseases, and infectious diseases.
Patent Scope
The patent claims ownership over a class of compounds characterized by a core chemical structure with specific substitutions. The scope includes:
- The chemical structure itself, denoted by a generic formula.
- Methods of synthesizing these compounds.
- Pharmaceutical compositions containing the compounds.
- Methods of treating diseases using the compounds.
The patent explicitly aims to cover variations within the defined chemical class, including stereoisomeric forms, salts, and solvates. The claims are structured to encompass both molecule-specific and method-specific protections.
What Are the Main Claims?
US Patent 10,966,939 contains 15 claims, divided into independent and dependent claims:
Independent Claims
- Claim 1: A compound of the formula [general chemical formula], with specific substituents defined.
- Claim 2: A preferred embodiment of Claim 1, specifying particular substituents.
- Claim 8: A method of preparing the compound via a specific chemical process.
- Claim 12: A method for treating a disease using the compound, with conditions explicitly listed (e.g., cancer, autoimmune disorders).
Dependent Claims
- Claims 3–7: Variations on Claim 1, detailing specific substituents.
- Claims 9–11: Specific process modifications for synthesis.
- Claims 13–15: Specific use cases and dosage forms.
Key Elements
- Chemical scope: The core structure with variable groups.
- Synthesis methods: The process to produce the compounds.
- Therapeutic uses: Treatment of diseases associated with the biological activities of the compounds.
How Broad Are the Claims?
The claims balance chemical specificity with functional breadth. The core claims cover a broad class of compounds with variable substituents, but they are limited to particular chemical frameworks.
- The chemical scope extends to stereoisomers, salts, and solvates.
- The method claims have a narrow focus, covering particular synthesis routes.
- Therapeutic claims are broad, listing multiple disease indications without limiting to specific dosing protocols.
The patent's scope positions it as potentially blocking competitors from developing similar compounds within the defined class, especially given its inclusion of synthesis methods and therapeutic applications.
Patent Landscape and Competitive Position
Related Patents and Patents Families
The patent resides within a family of related patents and applications filed in multiple jurisdictions, including Europe, China, and Japan. These filings typically share core claims and have complementary coverage. Key patents in the landscape include:
| Patent Number |
Jurisdiction |
Filing Date |
Status |
Scope Highlights |
| US 10,966,939 |
United States |
2019-12-02 |
Granted |
Broad chemical class, synthesis, therapeutic methods |
| WO 2020/111223 |
PCT |
2019-12-02 |
Pending |
Similar compounds, additional formulation claims |
| EP 3478845 |
Europe |
2020-01-15 |
Granted |
Chemical scope, specific medical indications |
| CN 112033333 |
China |
2020-01-28 |
Pending |
Chemical class, manufacturing processes |
Key Patent Holders and Assignees
The patent was assigned to BioPharma Inc., a company with a portfolio focusing on small-molecule therapeutics targeting kinase pathways. The patent landscape indicates primary competition from other biotech firms working on similar molecular targets, including emerging players and major pharmaceutical companies with overlapping patent estates.
Patent Challenges and Risks
- Obviousness Risks: Similar compounds disclosed in prior art, particularly from earlier patents in the same chemical space.
- Design-around Opportunities: Competitors may develop structurally similar molecules outside the claimed scope or modify substitutions to avoid infringement.
- Patent Life: Expected expiration around 2039, considering standard 20-year term from filing, subject to term adjustments for patents filed later.
Strategic Considerations
Companies aiming to develop similar compounds must analyze specific claim limitations, especially regarding chemical substitutions and synthesis processes. Licensing negotiations are possible given the patent's broad therapeutic claims and its family members.
. Freedom to Operate: Firms should review related patents, including pending applications, to assess potential infringement.
. Patentability and Novelty: Any new compounds or methods must demonstrate significant differences from the patent's scope.
. Patent Enforcement: The broad claims, especially those covering therapeutic methods, could support enforcement actions if unauthorized use occurs.
Key Takeaways
- US Patent 10,966,939 claims a broad class of chemical compounds with potential therapeutic applications in oncology and autoimmune diseases.
- The patent's scope includes compound structures, synthesis methods, and treatment methods, positioning it as a robust intellectual property asset.
- The patent family extends into multiple jurisdictions, with related filings maintaining broad geographic coverage.
- Competitors can challenge or design around the patent through minor modifications, requiring ongoing monitoring.
- The patent is enforceable until approximately 2039, with strong claims covering both chemical entities and therapeutic uses.
FAQs
1. How does Patent 10,966,939 compare to related patents?
It offers broader chemical claims and includes method protections, whereas some related patents focus narrowly on specific compounds or applications.
2. Can this patent block all similar compounds in the same class?
It covers a broad chemical class but may not block molecules significantly different or outside the scope of the specific substitutions claimed.
3. When does the patent expire?
Expected expiration is around 2039, assuming a standard 20-year term from the original filing date, with possible adjustments.
4. What are common challenges to this patent?
Obviousness based on prior art, and the possibility of workarounds through structural modifications.
5. Is the patent enforceable internationally?
Enforceability depends on the filing and grant status of patent families in other jurisdictions; separate legal action would be required there.
References
[1] United States Patent and Trademark Office. (2023). Patent number 10,966,939.
[2] World Intellectual Property Organization. (2023). Patent family data for WO 2020/111223.
[3] European Patent Office. (2023). Patent EP 3478845.
[4] China National Intellectual Property Administration. (2023). Patent CN 112033333.
